{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:56:37Z","timestamp":1780876597215,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":1203,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1111\/ajt.15312","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:26:49Z","timestamp":1550226409000},"page":"2274-2283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8495-9782","authenticated-orcid":false,"given":"Andrew","family":"Bentall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9318-2437","authenticated-orcid":false,"given":"Byron H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6971-3971","authenticated-orcid":false,"given":"Manuel Moreno","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7695-399X","authenticated-orcid":false,"given":"Keisha","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter D.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-3277","authenticated-orcid":false,"given":"Carrie A.","family":"Schinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Borrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Lefaucheur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Stegall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1111\/ajt.15312_bib1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"10.1111\/ajt.15312_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15312_bib3","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/TP.0000000000001619","article-title":"Kidney transplant with low levels of DSA or low positive B-flow crossmatch: an underappreciated option for highly-sensitized transplant candidates","volume":"101","author":"Schinstock","year":"2017","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.15312_bib4","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1111\/ajt.14494","article-title":"Overcoming preexisting alloantibody in renal transplantation-improving outcomes while reducing needs and costs","volume":"17","author":"Bentall","year":"2017","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15312_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1053\/j.ajkd.2013.10.059","article-title":"Predicting 5-year risk of kidney transplant failure: a prediction instrument using data available at 1 year posttransplantation","volume":"63","author":"Shabir","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"10","key":"10.1111\/ajt.15312_bib6","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1681\/ASN.2015070811","article-title":"Predicting individual renal allograft outcomes using risk models with 1-year surveillance biopsy and alloantibody data","volume":"27","author":"Gonzales","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1111\/ajt.15312_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2017070749","article-title":"Dynamic prognostic score to predict kidney allograft survival in patients with antibody-mediated rejection","volume":"29","author":"Viglietti","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"10.1111\/ajt.15312_bib8","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15312_bib9","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000001650","article-title":"Long-term outcomes of kidney transplantation in patients with high levels of preformed DSA: the Necker high-risk transplant program","volume":"101","author":"Amrouche","year":"2017","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.15312_bib10","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/j.1600-6143.2007.02010.x","article-title":"Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15312_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2215\/CJN.05030610","article-title":"Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration","volume":"6","author":"Ix","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"10.1111\/ajt.15312_bib12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ndt\/17.6.1081","article-title":"Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts","volume":"17","author":"Gough","year":"2002","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"10.1111\/ajt.15312_bib13","first-page":"1083","article-title":"Reproducibility of the Banff classification of renal allograft pathology","volume":"60","author":"Marcussen","year":"1995","journal-title":"Inter- and intraobserver variation. Transplantation."},{"issue":"S3","key":"10.1111\/ajt.15312_bib14","first-page":"411","article-title":"A method to reduce variability in diagnosing antibody mediated rejection in renal allograft biopsies using Banff 2013 [abstract]","volume":"17","author":"Smith","year":"2017","journal-title":"Am J Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15312","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:09Z","timestamp":1761629109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522091936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1600613522091936"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15312","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}